Eating Disorders in Individuals with Type 1 Diabetes: Case Series and day Hospital Treatment Outcome

Women with type 1 diabetes are at high risk for eating disorders (ED), a combination that can increase medical complications and mortality. As little is known about treatment response in this population, clinical presentation and treatment outcome in an extended case series were assessed. A chart re...

Full description

Saved in:
Bibliographic Details
Published in:European eating disorders review 2015-07, Vol.23 (4), p.312-317
Main Authors: Colton, Patricia Anne, Olmsted, Marion Patricia, Wong, Harmonie, Rodin, Gary Michael
Format: Article
Language:English
Subjects:
Adult
Comorbidity
Day Care, Medical
Diabetes
Diabetes Mellitus, Type 1 - diagnosis
Diabetes Mellitus, Type 1 - psychology
Diabetes Mellitus, Type 1 - therapy
eating disorder
Eating disorders
Feeding and Eating Disorders - diagnosis
Feeding and Eating Disorders - psychology
Feeding and Eating Disorders - therapy
Female
Follow-Up Studies
Humans
insulin omission
Male
Medical treatment
Middle Aged
Ontario
Retrospective Studies
Risk Factors
Treatment Outcome
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Women with type 1 diabetes are at high risk for eating disorders (ED), a combination that can increase medical complications and mortality. As little is known about treatment response in this population, clinical presentation and treatment outcome in an extended case series were assessed. A chart review at the Eating Disorders Day Hospital Program at Toronto General Hospital identified a total of 100 individuals with type 1 diabetes assessed 1990–2012. Of 37 who attended day hospital, most experienced improvement in ED symptoms, but only 18.8% had a good immediate treatment outcome, while 43.8% had an intermediate outcome and 37.5% had a poor outcome (meeting diagnostic criteria at discharge). This is poorer than program outcomes in individuals without diabetes (χ2 = 12.2, df = 2; p = 0.002). Factors influencing treatment engagement and outcome must be further studied and used to improve treatment results in this high‐risk group. Copyright © 2015 John Wiley & Sons, Ltd and Eating Disorders Association.
ISSN:1072-4133
1099-0968
DOI:10.1002/erv.2365